CFTR expression from a BAC carrying the complete human gene and associated regulatory elements

被引:11
作者
Kotzamanis, George [1 ,2 ]
Abdulrazzak, Hassan [2 ,3 ]
Gifford-Garner, Jennifer [3 ]
Haussecker, Pei Ling [4 ]
Cheung, Wing [2 ]
Grillot-Courvalin, Catherine [5 ]
Harris, Ann [4 ]
Kittas, Christos [1 ]
Kotsinas, Athanasios [1 ]
Gorgoulis, Vassilis G. [1 ]
Huxley, Clare [2 ]
机构
[1] Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, GR-11527 Athens, Greece
[2] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England
[3] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England
[4] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
[5] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris, France
关键词
CFTR; BAC; expression; recombineering; bacterial invasion; CYSTIC-FIBROSIS GENE; I-HYPERSENSITIVE SITES; NUMBER-DEPENDENT EXPRESSION; ION-TRANSPORT DEFECT; MESSENGER-RNA; TRANSGENIC MICE; DOUBLE-BLIND; MUTATIONS; DNA; IDENTIFICATION;
D O I
10.1111/j.1582-4934.2008.00433.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The use of genomic DNA rather than cDNA or mini-gene constructs in gene therapy might be advantageous as these contain intronic and long-range control elements vital for accurate expression. For gene therapy of cystic fibrosis though, no bacterial artificial chromosome (BAC), containing the whole CFTR gene is available. We have used Red homologous recombination to add a to a previously described vector to construct a new BAC vector with a 250.3-kb insert containing the whole coding region of the CFTR gene along with 40.1 kb of DNA 5' to the gene and 25 kb 3' to the gene. This includes all the known control elements of the gene. We evaluated expression by RT-PCR in CMT-93 cells and showed that the gene is expressed both from integrated copies of the BAC and also from episomes carrying the oriP/EBNA-1 element. Sequencing of the human CFTR mRNA from one clone showed that the BAC is functional and can generate correctly spliced mRNA in the mouse background. The BAC described here is the only CFTR genomic construct available on a convenient vector that can be readily used for gene expression studies or in vivo studies to test its potential application in gene therapy for cystic fibrosis.
引用
收藏
页码:2938 / 2948
页数:11
相关论文
共 55 条
  • [1] Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis:: a double-blind placebo-controlled trial
    Alton, EWFW
    Stern, M
    Farley, R
    Jaffe, A
    Chadwick, SL
    Phillips, J
    Davies, J
    Smith, SN
    Browning, J
    Davies, MG
    Hodson, ME
    Durham, SR
    Li, D
    Jeffery, PK
    Scallan, M
    Balfour, R
    Eastman, SJ
    Cheng, SH
    Smith, AE
    Meeker, D
    Geddes, DM
    [J]. LANCET, 1999, 353 (9157) : 947 - 954
  • [2] NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE
    ALTON, EWFW
    MIDDLETON, PG
    CAPLEN, NJ
    SMITH, SN
    STEEL, DM
    MUNKONGE, FM
    JEFFERY, PK
    GEDDES, DM
    HART, SL
    WILLIAMSON, R
    FASOLD, KI
    MILLER, AD
    DICKINSON, P
    STEVENSON, BJ
    MCLACHLAN, G
    DORIN, JR
    PORTEOUS, DJ
    [J]. NATURE GENETICS, 1993, 5 (02) : 135 - 142
  • [3] Functional human CFTR produced by a stable minichromosome
    Auriche, C
    Carpani, D
    Conese, M
    Caci, E
    Zegarra-Moran, O
    Donini, P
    Ascenzioni, F
    [J]. EMBO REPORTS, 2002, 3 (09) : 862 - 868
  • [4] Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene
    Aznarez, I
    Chan, EM
    Zielenski, J
    Blencowe, BJ
    Tsui, LC
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (16) : 2031 - 2040
  • [5] An overview of the pathogenesis of cystic fibrosis lung disease
    Boucher, RC
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (11) : 1359 - 1371
  • [6] LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS
    CAPLEN, NJ
    ALTON, EWFW
    MIDDLETON, PG
    DORIN, JR
    STEVENSON, BJ
    GAO, X
    DURHAM, SR
    JEFFERY, PK
    HODSON, ME
    COUTELLE, C
    HUANG, L
    PORTEOUS, DJ
    WILLIAMSON, R
    GEDDES, DM
    [J]. NATURE MEDICINE, 1995, 1 (01) : 39 - 46
  • [7] FAR UPSTREAM REGIONS OF CLASS-II MHC EA ARE NECESSARY FOR POSITION-INDEPENDENT, COPY-DEPENDENT EXPRESSION OF EA TRANSGENE
    CARSON, S
    WILES, MV
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (09) : 2065 - 2072
  • [8] LYMPHOCYTE MESSENGER-RNA AS A RESOURCE FOR DETECTION OF MUTATIONS AND POLYMORPHISMS IN THE CF GENE
    CHALKLEY, G
    HARRIS, A
    [J]. JOURNAL OF MEDICAL GENETICS, 1991, 28 (11) : 777 - 780
  • [9] VARIABLE DELETION OF EXON-9 CODING SEQUENCES IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MESSENGER-RNA TRANSCRIPTS IN NORMAL BRONCHIAL EPITHELIUM
    CHU, CS
    TRAPNELL, BC
    MURTAGH, JJ
    MOSS, J
    DALEMANS, W
    JALLAT, S
    MERCENIER, A
    PAVIRANI, A
    LECOCQ, JP
    CUTTING, GR
    GUGGINO, WB
    CRYSTAL, RG
    [J]. EMBO JOURNAL, 1991, 10 (06) : 1355 - 1363
  • [10] GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA
    CHU, CS
    TRAPNELL, BC
    CURRISTIN, S
    CUTTING, GR
    CRYSTAL, RG
    [J]. NATURE GENETICS, 1993, 3 (02) : 151 - 156